Sharon Bergeron

595 total citations
10 papers, 291 citations indexed

About

Sharon Bergeron is a scholar working on Neurology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Sharon Bergeron has authored 10 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Oncology. Recurrent topics in Sharon Bergeron's work include Childhood Cancer Survivors' Quality of Life (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Neuroblastoma Research and Treatments (3 papers). Sharon Bergeron is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Neuroblastoma Research and Treatments (3 papers). Sharon Bergeron collaborates with scholars based in United States, Denmark and Germany. Sharon Bergeron's co-authors include Brigitte C. Widemann, David J. Askenazi, Jesper Heldrup, Anushree C. Shirali, Alexander A. Vinks, Maureen M. O’Brien, Stefan Schwartz, Jennifer L. Pauley, Frank M. Balis and Kjeld Schmiegelow and has published in prestigious journals such as Cancer, The Oncologist and Journal of Pediatric Nursing.

In The Last Decade

Sharon Bergeron

10 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon Bergeron United States 8 152 98 80 71 60 10 291
Ci Pan China 14 157 1.0× 55 0.6× 109 1.4× 107 1.5× 70 1.2× 37 405
Frédéric Baleydier France 7 182 1.2× 117 1.2× 64 0.8× 64 0.9× 99 1.6× 26 369
Eric S. Schafer United States 11 200 1.3× 48 0.5× 159 2.0× 92 1.3× 115 1.9× 36 391
Elizabeth M. Alfaro Argentina 10 148 1.0× 55 0.6× 70 0.9× 44 0.6× 55 0.9× 20 277
A Boilletot France 9 87 0.6× 57 0.6× 70 0.9× 75 1.1× 77 1.3× 26 297
WA Kamps Netherlands 7 271 1.8× 86 0.9× 123 1.5× 67 0.9× 37 0.6× 11 394
Sidharth Totadri India 9 74 0.5× 26 0.3× 85 1.1× 51 0.7× 33 0.6× 41 254
Salma A. Al‐Hadad Iraq 9 87 0.6× 76 0.8× 61 0.8× 99 1.4× 37 0.6× 26 204
ZoAnn E. Dreyer United States 7 138 0.9× 19 0.2× 132 1.6× 57 0.8× 50 0.8× 8 276
Elva Jiménez‐Hernández Mexico 10 105 0.7× 27 0.3× 68 0.8× 95 1.3× 95 1.6× 33 312

Countries citing papers authored by Sharon Bergeron

Since Specialization
Citations

This map shows the geographic impact of Sharon Bergeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Bergeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Bergeron more than expected).

Fields of papers citing papers by Sharon Bergeron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Bergeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Bergeron. The network helps show where Sharon Bergeron may publish in the future.

Co-authorship network of co-authors of Sharon Bergeron

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Bergeron. A scholar is included among the top collaborators of Sharon Bergeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Bergeron. Sharon Bergeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bergeron, Sharon, et al.. (2019). Empowering Adolescents and Young Adults to Support, Lead, and Thrive: Development and Validation of an AYA Oncology Child Life Program. Journal of Pediatric Nursing. 47. 1–6. 5 indexed citations
2.
Huynh, Van & Sharon Bergeron. (2017). Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia. Clinical journal of oncology nursing. 21(5). E248–E259. 19 indexed citations
3.
Ramsey, Laura B., Frank M. Balis, Maureen M. O’Brien, et al.. (2017). Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance. The Oncologist. 23(1). 52–61. 141 indexed citations
4.
Bergeron, Sharon, et al.. (2016). Dinutuximab. Journal of Pediatric Oncology Nursing. 34(1). 5–12. 16 indexed citations
5.
Lones, Mark A., Nyla A. Heerema, Michelle M. Le Beau, et al.. (2006). Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08. Cancer Genetics and Cytogenetics. 172(1). 1–11. 39 indexed citations
6.
Lones, Mark A., Warren G. Sanger, Michelle M. Le Beau, et al.. (2004). Chromosome Abnormalities May Correlate With Prognosis in Burkitt/Burkitt-Like Lymphomas of Children and Adolescents. Journal of Pediatric Hematology/Oncology. 26(3). 169–178. 37 indexed citations
7.
Shiramizu, Bruce, Sherrie L. Perkins, Sharon Bergeron, et al.. (2004). Assessing Immunoglobulin Heavy Chain Rearrangements in Pediatric CD20-Positive and CD20-Negative Classic Hodgkin's Diseas. Clinical Lymphoma. 5(3). 184–189. 1 indexed citations
8.
Bracho, Francisco, Mark Krailo, Violet Shen, et al.. (2001). A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.. PubMed. 7(1). 58–67. 13 indexed citations
9.
Cairo, Mitchell S., Mark Krailo, Joel Weinthal, et al.. (1998). A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer Group.. PubMed. 83(7). 1449–60. 10 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ci Pan Breakdown of academic impact, for papers by Frédéric Baleydier Breakdown of academic impact, for papers by Eric S. Schafer Breakdown of academic impact, for papers by Elizabeth M. Alfaro Breakdown of academic impact, for papers by A Boilletot Breakdown of academic impact, for papers by WA Kamps Breakdown of academic impact, for papers by Sidharth Totadri Breakdown of academic impact, for papers by Salma A. Al‐Hadad Breakdown of academic impact, for papers by ZoAnn E. Dreyer Breakdown of academic impact, for papers by Elva Jiménez‐Hernández
Rankless by CCL
2026